share_log

Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%), etc.

Editas Medicine | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%)等

美股sec公告 ·  02/14 08:42
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息